Late Outcomes after Arterial Switch Operation for Taussig
Transcription
Late Outcomes after Arterial Switch Operation for Taussig
Late Outcomes after Arterial Switch Operation for Taussig‐Bing Anomaly: Can we afford Biventricular Repair? M Vergnat, A Baruteau, L Houyel, M Ly, R Roussin, V Lambert, E Belli Centre Chirurgical Marie Lannelongue / M3C Paris-South University, France NO DISCLOSURE ASO for TBA Background •DORV •Subpulmonary Malalignment VSD •Aorta D-malposed ≈ Side by side •Associated anomalies: AAO •Procedure of choice: ASO Taussig HB, Bing RJ. Am Heart J 1949;37(4):551‐9 ASO for TBA Rationale • Surgical Challenge • • • • Neonatal procedure Intracardiac baffling Coronary anatomy Associated Aortic Arch repair • Anatomic repair of Taussig‐Bing hearts. Serraf A et al. Circulation 1991 ;84:III200‐5. • Risk Factors influencing outcome ASO for TBA Methods Inclusion criteria Van Praagh: “real” DORV Sub-pulmonary VSD Bilateral Coni Mitro-pulmonary discontinuity GA out of RV (> 50% rule) No pulmonary stenosis ASO for TBA Patients • 1997-2010 • 69 patients: ASO 60 primary / 9 staged • Median age at repair: 24 (range: 4-618) days ≤1 month: n=38 (55%) ASO for TBA Patients Anatomy Great Vessels Side by side D-malposition PA-Aorte ratio Coronary pattern C or E A or D Commissural malalignment Aortic Arch Obstruction Outflow Tract Obstruction Right (sub-aortic) Left (sub-pulmonary) 47 (68%) 22 (32%) 1.5 (1-2.5) 38 (55%) 31 (45%) 6 (9%) 26 (38%) 10 (14%) 15 (22%) ASO for TBA Results Operative data Timing (min) bypass 184±64 X-clamp 114±33 DHCA (n=10) 30±9 LV to PA Tunnel PA 57 (83%) RV RA 7 (10%) 5 (7%) Dacron pericardium Goretex 56 (83%) 12 (17%) 1 (2%) ASO for TBA Results Operative data Associated procedures Aortic Arch repair homograft / direct 26 (38%) 21 / 5 RVOTO relief (subAortic) 12 (17%) LVOTO relief (subPulmonary) 4 (6%) Pulmonary bifurcation translation VSD closure PAB 4 (6%) 2 (3%) 1 (2%) ASO for TBA Results Mortality • Early Mortality: n=4 (5.8%, 95%CI 1.6-14.2) - Coronary anatomy: 3 type E, 1 type C - Delay: perop., H+6, D3 and D11 (1 ECMO) - Cause: myocardial ischemia ASO for TBA Results Overall outcome « Late » mortality: n=5 (7.7%) (<1year) (3 Sudden Deaths, 2 Biventricular failures) All patients 53 53 49 40 32 Years Survival ASO for TBA Results Overall outcome Type A & D All patients Type C & E Log-Rank Test Type C & E vs. A & D p=0.04 Years Survival ASO for TBA Results Overall outcome Median Follow-up 11.2 years (0.1-16.2) All patients 85±4% at one and 10 years 53 53 49 40 32 Years Survival ASO for TBA Results Surg. and Cath. Reinterventions All patients 58±7% at 10 years 45 41 36 23 17 Years Freedom from Reintervention ASO for TBA Results Surg. and Cath. Reinterventions RVOT+PA LVOT+Aorta All patients Years Freedom from Reintervention ASO for TBA Results Reinterventions (n=38 in 21 pts,40%) 9 (17%) Catheter Aortic Arch PA 8 5 balloon or stent balloon or stent Surgery LVOTO Aortic Valve: remplacement/repair Reccurent Arch obstruction 13 19 (36%) 25 8 5/3 3 Pulmonary arterioplasty RVOTO 11 5 VSD Coronary 4 3 ASO for TBA Results Surg. and Cath. Reinterventions All patients 45 41 36 23 17 Years Freedom from Reintervention ASO for TBA Results Surg. and Cath. Reinterventions Risk factor Normal Arch All patients Obstructed Arch Log-Rank Test Normal Arch vs. Obstructed Arch p=0.006 Years Freedom from Reintervention ASO for TBA Results Surg. and Cath. Reinterventions Risk factor Crafoord p=0.002 AAO Reint. AAO p=0.02 postOp AR≥2 p=0.02 p=0.03 PA/Ao >2 p=0.04 RVOTO Reint. ARegurg Reint. ASO for TBA Results Follow-Up • Median Follow-up 11.2 years (0.1-16.2) • 60 survivors: - 96% NYHA1 - 98% sinus and normal BiV function - 1 Heart Transplant - 74% « normal » echocardiography: • 9% AVR, 4% grade3 AR, 17% grade 2 • 13% mild (L/R) VOTO • 7% medical AAO ASO for TBA Conclusions • Complex anomaly/procedure • Early outcome (mortality) • 1st year, coronary-related Early identification of lesions at risk Long-term outcome: > 10 y (reinterventions) Sustained functional outcome, no mortality Reinterventions ↔ Ao. Arch Obstruction Neo-Aortic root preservation: (patch augmentation, VSD closure technique) preventive management of RVOT at risk for obstruction